Potential in the Colombian medical device market
Medical devices are one of the most profitable niches in Colombian health. Marisol Sanchez, president of the Camara de Proveedores de Salud, notes that “the medical device sector correlated to…
Address: C Calle 93 B #17–25/49, Piso 5
Bogotá, Colombia
Tel: + 57 1 621 6600
Web: http://www.genzyme.com.co/default_co.asp
Genzyme de Colombia S.A., a subsidiary of Genzyme Corporation, is a growing organization that began its first activities in the country in 1996 through an external consultant for the purpose of registering Ceredase ®, the enzyme for treating Gaucher disease.
Since then, Genzyme de Colombia S.A.’s commitment has been to the continued support of patients, families and health specialists involved with the comprehensive management of lysosomal storage diseases.
It is Genzyme de Colombia S.A.’s mission to collaborate fully for the best quality and life expectancy of all patients in both Colombia and the Andean Pact affected by these diseases and who require on our part a sense of urgency that is present in all our employees.
From the moment Genzyme de Colombia S.A.’s began operations, even before the formal establishment of Genzyme de Colombia SA, the company has been working hard in deepening the knowledge within the medical profession of these diseases, which although of low incidence, significantly impact the patients affected by them.
Support for the medical community and health system in the best knowledge and comprehensive treatment of these diseases resulted in the formal establishment of Genzyme de Colombia S.A. in April 2002.
In July 1998 Genzyme de Colombia S.A. obtained the medical records for Cerezyme ® the first recombinant enzyme approved by the FDA for the treatment of Gaucher disease. In addition Genzyme de Colombia S.A. is currently marketing in Colombia Fabrazyme ® and Aldurazyme ®, the two recombinant enzymes approved by the FDA and the EMEA for the treatment of Fabry disease and MPS1 (Mucopolysaccharidosis 1), respectively.
Similarly, Genzyme de Colombia S.A. has a regional team committed to supporting patients with chronic renal failure and transplantation. We have obtained registration in Colombia for Renagel ® (sevelamer) for the treatment of phosphorus in dialysis patients.
Rare genetic disorders, kidney disease, osteoarthritis, and immunological diseases.
Medical devices are one of the most profitable niches in Colombian health. Marisol Sanchez, president of the Camara de Proveedores de Salud, notes that “the medical device sector correlated to…
President Santos appointed economist Alejandro Gaviria as the new Minister of Health and Social Protection in September 2012. Gaviria’s priority has been to create health reform that would introduce…
Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. Thanks to the ratification of free trade agreements with 14 countries around the…
Carlos Manuel González Parra discusses the progress Novo Nordisk has made as a newcomer to the Colombian market and its hopes and intentions for the future. One of the main…
Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The…
As a means of introduction, could you describe your background and how you became involved with Nutripharma in the first place? Nutripharma is a 12-year-old family company created by my…
Can you trace the evolution of the Colombian economy over the last few years? The Colombian economy is experiencing a time of significant growth with production and investment projects as…
Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you…
What is your background, and how did you become involved with Grupo Amarey? My first job in the medical industry was with Johnson & Johnson Medical, which back then was…
In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments…
The operations and sales managers of Cegedim Colombia discuss the impact of healthcare reform on the Colombian pharma market, partnering opportunities in the…
You have an extensive background in the healthcare sector, with positions in Colciencias, the Department of Public Health, and the National University of Colombia. What can you bring from these…
See our Cookie Privacy Policy Here
